Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2017, Article ID 5128760, 9 pages
https://doi.org/10.1155/2017/5128760
Review Article

Imaging the Abdominal Manifestations of Cystic Fibrosis

1Department of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland
2Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland
3University College of Dublin School of Medicine, Dublin, Ireland
4Department of Radiology, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114, USA

Correspondence should be addressed to C. D. Gillespie; moc.liamg@lligaraic

Received 28 August 2016; Revised 17 December 2016; Accepted 9 January 2017; Published 29 January 2017

Academic Editor: Pierluigi Toniutto

Copyright © 2017 C. D. Gillespie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. M. Pollock, “The treatment of cystic fibrosis in Ireland: problems and solutions,” The Cystic Fibrosis Association of Ireland, vol. 1, pp. 1–30, 2005. View at Google Scholar
  2. T. F. Boat, “Cystic fibrosis,” in Nelson Textbook of Paediatrics, R. E. Behrman, R. M. Kliegman, and H. B. Jenson, Eds., pp. 1437–1450, Saunders, Philadelphia, Pa, USA, 17th edition, 2004. View at Google Scholar
  3. M. R. Knowles and M. Drumm, “The influence of genetics on cystic fibrosis phenotypes,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 12, Article ID a009548, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Efrati, A. Barak, D. Modan-Moses et al., “Liver cirrhosis and portal hypertension in cystic fibrosis,” European Journal of Gastroenterology and Hepatology, vol. 15, no. 10, pp. 1073–1078, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Rowland, C. Gallagher, C. G. Gallagher et al., “Outcome in patients with cystic fibrosis liver disease,” Journal of Cystic Fibrosis, vol. 14, no. 1, pp. 120–126, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. L. P. Lavelle, S. H. McEvoy, E. Ni Mhurchu et al., “Cystic fibrosis below the diaphragm: abdominal findings in adult patients,” Radiographics, vol. 35, no. 3, pp. 680–695, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. M. B. Robertson, K. A. Choe, and P. M. Joseph, “Review of the abdominal manifestations of cystic fibrosis in the adult patient,” Radiographics, vol. 26, no. 3, pp. 679–690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. C. R. Marino and F. S. Gorelick, “Scientific advances in cystic fibrosis,” Gastroenterology, vol. 103, no. 2, pp. 681–693, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Nakamura, N. Katada, A. Sakakibara et al., “Huge lipomatous pseudohypertrophy of the pancreas,” The American Journal of Gastroenterology, vol. 72, no. 2, pp. 171–174, 1979. View at Google Scholar · View at Scopus
  10. B. J. Plant, C. H. Goss, W. D. Plant, and S. C. Bell, “Management of comorbidities in older patients with cystic fibrosis,” The Lancet Respiratory Medicine, vol. 1, no. 2, pp. 164–174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. R. Perez-Brayfield, D. Caplan, J. M. Gatti, E. A. Smith, and A. J. Kirsch, “Metabolic risk factors for stone formation in patients with cystic fibrosis,” Journal of Urology, vol. 167, no. 2 I, pp. 480–484, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Nazareth and M. Walshaw, “A review of renal disease in cystic fibrosis,” Journal of Cystic Fibrosis, vol. 12, no. 4, pp. 309–317, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Terribile, M. Capuano, G. Cangiano et al., “Factors increasing the risk for stone formation in adult patients with cystic fibrosis,” Nephrology Dialysis Transplantation, vol. 21, no. 7, pp. 1870–1875, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. B. S. Quon, N. Mayer-Hamblett, M. L. Aitken, A. R. Smyth, and C. H. Goss, “Risk factors for chronic kidney disease in adults with cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 10, pp. 1147–1152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Mckeon, A. Day, J. Parmar, G. Alexander, and D. Bilton, “Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis,” Journal of Cystic Fibrosis, vol. 3, no. 3, pp. 193–195, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Kelleher, M. Staunton, S. O'Mahony, and P. A. McCormick, “Advanced hepatocellular carcinoma associated with cystic fibrosis,” European Journal of Gastroenterology and Hepatology, vol. 17, no. 10, pp. 1123–1124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. D. H. O'Donnell, R. Ryan, B. Hayes, D. Fennelly, and R. G. Gibney, “Hepatocellular carcinoma complicating cystic fibrosis related liver disease,” Journal of Cystic Fibrosis, vol. 8, no. 4, pp. 288–290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. R. Bartlett, K. J. Friedman, S. C. Ling et al., “Genetic modifiers of liver disease in cystic fibrosis,” The Journal of the American Medical Association, vol. 302, no. 10, pp. 1076–1083, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Flass and M. R. Narkewicz, “Cirrhosis and other liver disease in cystic fibrosis,” Journal of Cystic Fibrosis, vol. 12, no. 2, pp. 116–124, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Debray, D. Kelly, R. Houwen, B. Strandvik, and C. Colombo, “Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease,” Journal of Cystic Fibrosis, vol. 10, no. 2, pp. S29–S36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. P. J. Lewindon, R. W. Shepherd, M. J. Walsh et al., “Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy,” Hepatology, vol. 53, no. 1, pp. 193–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Y. Ooi, “Letter to the Editor: ursodeoxycholic acid in cystic fibrosis-associated liver disease,” Journal of Cystic Fibrosis, vol. 11, no. 1, pp. 72–73, 2012. View at Publisher · View at Google Scholar
  23. T. N. Pereira, P. J. Lewindon, J. L. Smith et al., “Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease,” Journal of Hepatology, vol. 41, no. 4, pp. 576–583, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. G. A. Ramm, R. W. Shepherd, A. C. Hoskins et al., “Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment,” Hepatology, vol. 49, no. 2, pp. 533–544, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. H. Leung, M. Khan, C. G. Minard et al., “Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease,” Hepatology, vol. 62, no. 5, pp. 1576–1583, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. G. A. Agrons, W. R. Corse, R. I. Markowitz, E. S. Suarez, and D. R. Perry, “Gastrointestinal manifestations of cystic fibrosis: radiologic-pathologic correlation,” Radiographics, vol. 16, no. 4, pp. 871–893, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. L. J. King, E. D. Scurr, N. Murugan, S. G. J. Williams, D. Westaby, and J. C. Healy, “Hepatobiliary and pancreatic manifestations of cystic fibrosis: MR imaging appearances,” Radiographics, vol. 20, no. 3, pp. 767–777, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. C. C. Roy, A. M. Weber, C. L. Morin et al., “Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes,” New England Journal of Medicine, vol. 297, no. 24, pp. 1301–1305, 1977. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Durieu, O. Pellet, L. Simonot et al., “Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study,” Journal of Hepatology, vol. 30, no. 6, pp. 1052–1056, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. U. Herrmann, G. Dockter, and F. Lammert, “Cystic fibrosis-associated liver disease,” Best Practice and Research: Clinical Gastroenterology, vol. 24, no. 5, pp. 585–592, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Akata and O. Akhan, “Liver manifestations of cystic fibrosis,” European Journal of Radiology, vol. 61, no. 1, pp. 11–17, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. D. M. Torres, C. D. Williams, and S. A. Harrison, “Features, diagnosis and treatment of non-alcoholic fatty liver disease,” Clinical Gastroenterology and Hepatology, vol. 10, no. 8, pp. 837–858, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Singh, A. M. Allen, Z. Wang, L. J. Prokop, M. H. Murad, and R. Loomba, “Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies,” Clinical Gastroenterology and Hepatology, vol. 13, no. 4, pp. 643–654, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Pais, F. Charlotte, L. Fedchuk et al., “A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver,” Journal of Hepatology, vol. 59, no. 3, pp. 550–556, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Colombo, P. M. Battezzati, A. Crosignani et al., “Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome,” Hepatology, vol. 36, no. 6, pp. 1374–1382, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Chryssostalis, D. Hubert, J. Coste et al., “Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation,” Journal of Hepatology, vol. 55, no. 6, pp. 1377–1382, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. K. L. Nash, M. E. Allison, D. McKeon et al., “A single centre experience of liver disease in adults with cystic fibrosis 1995–2006,” Journal of Cystic Fibrosis, vol. 7, no. 3, pp. 252–257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. F. Hanna, D. A. Aguirre, N. Kased, S. C. Emery, M. R. Peterson, and C. B. Sirlin, “Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features,” Radiographics, vol. 28, no. 3, pp. 747–769, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. P. R. Mueller-Abt, K. J. Frawley, R. M. Greer, and P. J. Lewindon, “Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease,” Journal of Cystic Fibrosis, vol. 7, no. 3, pp. 215–221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Witters, K. De Boeck, L. Dupont et al., “Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease,” Journal of Cystic Fibrosis, vol. 8, no. 6, pp. 392–399, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Friedrich-Rust, N. Schlueter, C. Smaczny et al., “Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis,” Journal of Cystic Fibrosis, vol. 12, no. 5, pp. 431–439, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Karlas, M. Neuschulz, A. Oltmanns et al., “Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores,” PLoS ONE, vol. 7, no. 7, Article ID e42139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Lemaitre, S. Dominique, E. Billoud et al., “Relevance of 3D cholangiography and transient elastography to assess cystic fibrosis-associated liver disease?” Canadian Respiratory Journal, vol. 2016, Article ID 4592702, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Karlas, M. Neuschulz, A. Oltmanns, H. Wirtz, V. Keim, and J. Wiegand, “ARFI and transient elastography for characterization of cystic fibrosis related liver disease: first longitudinal follow-up data in adult patients,” Journal of Cystic Fibrosis, vol. 12, no. 6, pp. 826–827, 2013. View at Publisher · View at Google Scholar · View at Scopus